Tissue Sealants - Medical Devices Pipeline Assessment, 2017

  • ID: 4401990
  • Report
  • 173 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Adhesys Medical GmbH
  • C. R. Bard Inc
  • Emory University
  • Hemostasis LLC
  • LifeBond Ltd
  • Sealantis Ltd.
  • MORE
Tissue Sealants - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Tissue Sealants - Medical Devices Pipeline Assessment, 2017" provides an overview of Tissue Sealants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Sealants pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Sealants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Sealants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adhesys Medical GmbH
  • C. R. Bard Inc
  • Emory University
  • Hemostasis LLC
  • LifeBond Ltd
  • Sealantis Ltd.
  • MORE
1 Table of Contents
2 Introduction
2.1 Tissue Sealants Overview
3 Products under Development
3.1 Tissue Sealants - Pipeline Products by Stage of Development
3.2 Tissue Sealants - Pipeline Products by Segment
3.3 Tissue Sealants - Pipeline Products by Territory
3.4 Tissue Sealants - Pipeline Products by Regulatory Path
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date
3.6 Tissue Sealants - Ongoing Clinical Trials
4 Tissue Sealants - Pipeline Products under Development by Companies
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development
4.2 Tissue Sealants - Pipeline Products by Stage of Development
5 Tissue Sealants Companies and Product Overview
5.1 Adhesys Medical GmbH Company Overview
5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Medical Solutions Group plc Company Overview
5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Argon Medical Devices Inc Company Overview
5.3.1 Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Baxter International Inc Company Overview
5.4.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Biomedica Management Corp Company Overview
5.5.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 Boston University Company Overview
5.6.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview
5.7 C. R. Bard Inc Company Overview
5.7.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Clemson University Company Overview
5.8.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview
5.9 Cohera Medical Inc Company Overview
5.9.1 Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Covalent Medical, Inc. (Inactive) Company Overview
5.10.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 DSM Biomedical BV Company Overview
5.11.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
5.12 Emory University Company Overview
5.12.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.13 Ethicon Endo-Surgery Inc Company Overview
5.13.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Gamma Therapeutics Inc Company Overview
5.14.1 Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Gecko Biomedical Company Overview
5.15.1 Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview
5.16 Grifols SA Company Overview
5.16.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
5.17 Hemostasis LLC Company Overview
5.17.1 Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 HyperBranch Medical Technology Inc Company Overview
5.18.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Institute of Molecular Biology of Parana Company Overview
5.19.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview
5.20 InVivo Therapeutics Corp Company Overview
5.20.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.21 John Hopkins University Company Overview
5.21.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.22 Kollodis BioSciences Inc Company Overview
5.22.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Kuros Biosciences AG Company Overview
5.23.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
5.24 LifeBond Ltd Company Overview
5.24.1 LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Medisse BV (Inactive) Company Overview
5.25.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.26 Pharming Group NV Company Overview
5.26.1 Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview
5.27 Polyganics BV Company Overview
5.27.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview
5.28 Protein Polymer Technologies Inc (Inactive) Company Overview
5.28.1 Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.29 Sea Run Holdings Inc Company Overview
5.29.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Sealantis Ltd. Company Overview
5.30.1 Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.31 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.31.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.32 Surgical Sealants, Inc. Company Overview
5.32.1 Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.33 Teijin Pharma Ltd Company Overview
5.33.1 Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Texas A&M University Company Overview
5.34.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
5.35 The Medicines Company Company Overview
5.35.1 The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview
5.36 University of Akron Company Overview
5.36.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview
6 Tissue Sealants- Recent Developments
6.1 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017
6.2 Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors
6.3 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery
6.4 Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN
6.5 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.6 Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results
6.7 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results
6.8 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions
6.9 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
6.10 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.11 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results
6.12 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
6.13 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer
6.14 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact
6.15 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.16 May 24, 2017: Gecko Biomedical Appoints Youssef Biadillah as Chief Development Officer. Maria Pereira Transitions to Chief Innovation Officer
6.17 May 11, 2017: Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update
6.18 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
6.19 May 03, 2017: Bioscience Division sales increase 15% to drive Grifols' revenue growth by 11% to Euros 1,062 million
6.20 May 02, 2017: Medline Names New President of Canadian Business
6.21 Apr 28, 2017: Kuros Biosciences Proposes Election of Four New Board Members
6.22 Apr 28, 2017: Advanced Medical Solutions Group Reports 2016 Financial Results
6.23 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017
6.24 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
6.25 Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results
6.26 Apr 26, 2017: Kuros Biosciences Reports Financial Results for 2016
6.27 Apr 23, 2017: Bard Announces First Quarter Results
6.28 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results
6.29 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results
6.30 Apr 13, 2017: Kuros announces CEO succession
6.31 Apr 03, 2017: Cesca Therapeutics Announces Senior Management Promotions
6.32 Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors
6.33 Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016
6.34 Mar 06, 2017: Medline Announces New Chief Marketing Officer
6.35 Feb 28, 2017: Grifols' revenues exceed Euros 4,000 million, driven by +6.5% growth of the Bioscience Division
6.36 Feb 28, 2017: The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.37 Feb 28, 2017: Cesca Therapeutics Strengthens Leadership Team and Board of Directors
6.38 Feb 22, 2017: LifeBond's Multi-Center International Pivotal Study of the LifeSeal Surgical Sealant for GI Resections is Enrolling Patients in the US and Europe
6.39 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.40 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
6.41 Feb 13, 2017: Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update
6.42 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
6.43 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.44 Feb 06, 2017: Teijin Board Elects Akihisa Nabeshima as New President of Teijin Pharma
6.45 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
6.46 Jan 26, 2017: Bard Announces Fourth Quarter Results
6.47 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results
6.48 Jan 17, 2017: Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors
6.49 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care
6.50 Jan 03, 2017: Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Colorectal Surgery
6.51 Dec 30, 2016: Medline Makes it Easier for Patients to Receive Critical Supplies through New Patient Home Direct Deal with ViaQuest
6.52 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.53 Nov 17, 2016: Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update
6.54 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.55 Nov 08, 2016: Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million
6.56 Nov 04, 2016: InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update
6.57 Nov 03, 2016: DSM Q3 2016 Results
6.58 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results
6.59 Oct 26, 2016: The Medicines Company Reports Third-Quarter 2016 Financial Results
6.60 Oct 25, 2016: EVARREST Fibrin Sealant Patch Gains FDA Approval On Expanded Indication For General Hemostasis
6.61 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
6.62 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors
6.63 Oct 25, 2016: Bard Announces Third Quarter Results
6.64 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
6.65 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Tissue Sealants - Pipeline Products by Stage of Development
Table 2: Tissue Sealants - Pipeline Products by Segment
Table 3: Tissue Sealants - Pipeline Products by Territory
Table 4: Tissue Sealants - Pipeline Products by Regulatory Path
Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date
Table 6: Tissue Sealants - Ongoing Clinical Trials
Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development
Table 8: Tissue Sealants - Pipeline Products by Stage of Development
Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: CUTIS - Product Status
Table 11: CUTIS - Product Description
Table 12: Tissue Adhesive - Pancreatectomy - Product Status
Table 13: Tissue Adhesive - Pancreatectomy - Product Description
Table 14: VIVO - Product Status
Table 15: VIVO - Product Description
Table 16: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: LiquiBand - Product Status
Table 18: LiquiBand - Product Description
Table 19: Next Generation Internal Fixation And Sealant Device - Product Status
Table 20: Next Generation Internal Fixation And Sealant Device - Product Description
Table 21: Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Hemaseel HMN Fibrin Sealant - Product Status
Table 23: Hemaseel HMN Fibrin Sealant - Product Description
Table 24: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Tisseel Dura - Product Status
Table 26: Tisseel Dura - Product Description
Table 27: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 28: ClotBlock - Product Status
Table 29: ClotBlock - Product Description
Table 30: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Hydrogel-based Aerosolized Sealant Dressing - Product Status
Table 32: Hydrogel-based Aerosolized Sealant Dressing - Product Description
Table 33: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Progel Dural Sealant - Product Status
Table 35: Progel Dural Sealant - Product Description
Table 36: Progel Emerald - Product Status
Table 37: Progel Emerald - Product Description
Table 38: Tridyne Peripheral - Product Status
Table 39: Tridyne Peripheral - Product Description
Table 40: Clemson University Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Surgical Adhesive Hydrogel - Product Status
Table 42: Surgical Adhesive Hydrogel - Product Description
Table 43: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Sylys Surgical Sealant - Product Status
Table 45: Sylys Surgical Sealant - Product Description
Table 46: Sylys Surgical Sealant - Drug Delivery - Product Status
Table 47: Sylys Surgical Sealant - Drug Delivery - Product Description
Table 48: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status
Table 49: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description
Table 50: Sylys Surgical Sealant - Orthopedic Procedures - Product Status
Table 51: Sylys Surgical Sealant - Orthopedic Procedures - Product Description
Table 52: Cohera Medical Inc - Ongoing Clinical Trials Overview
Table 53: Sylys Surgical Sealant - A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant
Table 54: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant
Table 55: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Covabond - Product Status
Table 57: Covabond - Product Description
Table 58: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Dural Membrane Sealant - Product Status
Table 60: Dural Membrane Sealant - Product Description
Table 61: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Steroidal Hemostatic Surgical Adhesive - Product Status
Table 63: Steroidal Hemostatic Surgical Adhesive - Product Description
Table 64: Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Bioseal Next Gen Device - Product Status
Table 66: Bioseal Next Gen Device - Product Description
Table 67: Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: GammaSeal - Product Status
Table 69: GammaSeal - Product Description
Table 70: Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Bio-Inspired Surgical Liquid Film - Product Status
Table 72: Bio-Inspired Surgical Liquid Film - Product Description
Table 73: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Fibrin Biological Glue - Product Status
Table 75: Fibrin Biological Glue - Product Description
Table 76: Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Advanced Tissue Sealant - Product Status
Table 78: Advanced Tissue Sealant - Product Description
Table 79: Bioabsorbable Bone Sealant - Product Status
Table 80: Bioabsorbable Bone Sealant - Product Description
Table 81: HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Adherus Vascular Sealant - Product Status
Table 83: Adherus Vascular Sealant - Product Description
Table 84: Tissue Plane Sealant - Product Status
Table 85: Tissue Plane Sealant - Product Description
Table 86: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Recombinant Fibrin Glue - Product Status
Table 88: Recombinant Fibrin Glue - Product Description
Table 89: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 90: InVivoSeal - Product Status
Table 91: InVivoSeal - Product Description
Table 92: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Chondroitin Sulfate-based Adhesive - Product Status
Table 94: Chondroitin Sulfate-based Adhesive - Product Description
Table 95: Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Hemostat Sealant - Product Status
Table 97: Hemostat Sealant - Product Description
Table 98: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 99: KUR - 212 - Product Status
Table 100: KUR - 212 - Product Description
Table 101: LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 102: LifeSeal Surgical Sealant - Product Status
Table 103: LifeSeal Surgical Sealant - Product Description
Table 104: Tissue Adhesive - Product Status
Table 105: Tissue Adhesive - Product Description
Table 106: LifeBond Ltd - Ongoing Clinical Trials Overview
Table 107: LifeSeal Surgical Sealant - Efficacy and Safety of LifeSeal Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
Table 108: LifeSeal Surgical Sealant - Observational, Retrospective and Prospective, One Arm, Registry Study for the Effectiveness of LifeSeal Kit on Anastomotic Leaks in Patients Undergoing Low and Ultralow Anterior Resection: SEAL Registry
Table 109: Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 110: PTMC Sealant - Product Status
Table 111: PTMC Sealant - Product Description
Table 112: Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview
Table 113: Recombinant Fibrin Tissue Sealant - Product Status
Table 114: Recombinant Fibrin Tissue Sealant - Product Description
Table 115: Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Dura Sealant Patch - Product Status
Table 117: Dura Sealant Patch - Product Description
Table 118: Liver Sealant Patch - Product Status
Table 119: Liver Sealant Patch - Product Description
Table 120: Pancreas Sealant Patch - Product Status
Table 121: Pancreas Sealant Patch - Product Description
Table 122: Spine Sealant Patch - Product Status
Table 123: Spine Sealant Patch - Product Description
Table 124: Polyganics BV - Ongoing Clinical Trials Overview
Table 125: Dura Sealant Patch - A Randomized Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 S-apr) Compared to DuraSeal Dural Sealant as an Adjunct to Sutured Dural Repair in Cranial Surgery
Table 126: Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Surgical Tissue Sealant - Product Status
Table 128: Surgical Tissue Sealant - Product Description
Table 129: Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 130: SEA-STAT CNS - Product Status
Table 131: SEA-STAT CNS - Product Description
Table 132: Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 133: Seal-G - Product Status
Table 134: Seal-G - Product Description
Table 135: Sealantis Tissue Adhesive - Product Status
Table 136: Sealantis Tissue Adhesive - Product Description
Table 137: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Fibrinsealant - Product Status
Table 139: Fibrinsealant - Product Description
Table 140: Fibrinsealant Powder - Product Status
Table 141: Fibrinsealant Powder - Product Description
Table 142: Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Thorex - Product Status
Table 144: Thorex - Product Description
Table 145: Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 146: KTF-374 Fibrin Sealant - Product Status
Table 147: KTF-374 Fibrin Sealant - Product Description
Table 148: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
Table 149: Tissue Welding Device - Product Status
Table 150: Tissue Welding Device - Product Description
Table 151: Wound Healing and Tissue Repair Bandage - Product Status
Table 152: Wound Healing and Tissue Repair Bandage - Product Description
Table 153: The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Prevent GI Sealant - Product Status
Table 155: Prevent GI Sealant - Product Description
Table 156: University of Akron Pipeline Products & Ongoing Clinical Trials Overview
Table 157: Wound Closure Glue - Product Status
Table 158: Wound Closure Glue - Product Description
Table 159: Glossary

List of Figures
Figure 1: Tissue Sealants - Pipeline Products by Stage of Development
Figure 2: Tissue Sealants - Pipeline Products by Segment
Figure 3: Tissue Sealants - Pipeline Products by Territory
Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path
Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Sealants - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Adhesys Medical GmbH
  • Advanced Medical Solutions Group plc
  • Argon Medical Devices Inc
  • Baxter International Inc
  • Biomedica Management Corp
  • Boston University
  • C. R. Bard Inc
  • Clemson University
  • Cohera Medical Inc
  • Covalent Medical, Inc.
  • DSM Biomedical BV
  • Emory University
  • Ethicon Endo-Surgery Inc
  • Gamma Therapeutics Inc
  • Gecko Biomedical
  • Grifols SA
  • Hemostasis LLC
  • HyperBranch Medical Technology Inc
  • Institute of Molecular Biology of Parana
  • InVivo Therapeutics Corp
  • John Hopkins University
  • Kollodis BioSciences Inc
  • Kuros Biosciences AG
  • LifeBond Ltd
  • Medisse BV
  • Pharming Group NV
  • Polyganics BV
  • Protein Polymer Technologies Inc
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Shanghai Haohai Biological Technology Co Ltd
  • Surgical Sealants, Inc.
  • Teijin Pharma Ltd
  • Texas A&M University
  • The Medicines Company
  • University of Akron
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll